Skip to main content
BioSenic SA logo

BioSenic SA — Investor Relations & Filings

Ticker · BIOS ISIN · BE0974280126 LEI · 549300HFIIMTOP1DFR76 BR Professional, scientific and technical activities
Open in API
Filings indexed 968 across all filing types
Latest filing 2022-10-11 Director's Dealing
Country BE Belgium
Listing BR BIOS

About BioSenic SA

http://www.biosenic.com/

BioSenic SA is a biotechnology company focused on developing innovative treatments for autoimmune diseases, inflammatory conditions, and bone disorders. The company's core activities are centered on two main technology platforms: one based on arsenic trioxide (ATO) for its immunomodulatory properties, and another involving allogeneic cell therapy for tissue repair and regeneration. BioSenic's objective is to address significant unmet medical needs in the fields of regenerative and immune medicine by advancing its clinical assets through development.

Recent filings

Filing Released Lang Actions
BOTHE_PR_2022-10-11_Transparency Notification_S.F.P.I_EN_Final.pdf
Director's Dealing Classification · 98% confidence The document is explicitly titled 'PRESS RELEASE – REGULATED INFORMATION' and announces that the company 'received a transparency notification from S.F.P.I... dated 04 October 2022.' The content details the crossing of a major shareholding threshold (below 5%) as per 'Article 14 of the Law of 2 May 2007 on disclosure of major holdings.' This type of filing, which reports changes in significant ownership stakes, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is presented as a press release, the core information is the notification of a change in major shareholding.
2022-10-11 English
BOTHE_PR_2022-10-11_Transparency Notification_S.F.P.I_FR_Final.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled 'COMMUNIQUÉ DE PRESSE - INFORMATION RÉGLEMENTÉE' (Press Release - Regulated Information) and dated October 11, 2022. The core content is the 'Notification de transparence reçue de la part de S.F.P.I/F.P.I.M' (Transparency notification received from S.F.P.I/F.P.I.M) regarding a change in significant shareholding (crossing the 5% threshold downwards). This directly corresponds to the definition of a Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels crossing thresholds, as mandated by transparency laws (Article 14 mentioned). Although it is a press release, the specific subject matter dictates the classification over a general Regulatory Filing (RNS).
2022-10-11 French
BOTHE_PR_2022-10-07_Pregene_Termination notice_EN_FINAL.pdf
Legal Proceedings Report Classification · 99% confidence The document is explicitly titled 'PRESS RELEASE – INSIDE INFORMATION' and dated '7 October 2022'. It announces a significant corporate event: Bone Therapeutics regaining worldwide rights to its ALLOB platform following a unilateral termination notice from a partner (Pregene). This type of material, which conveys material, non-public information to the market, is typically classified as a general regulatory announcement or press release. Since it is not a full Annual Report (10-K), a specific financial statement (IR, MRQ), a transcript (CT), or a specific governance/remuneration document (DEF 14A, CGR), the most appropriate category is the general regulatory filing/announcement fallback, RNS (Regulatory Filings). The length (7755 chars) is substantial enough that it is the primary announcement itself, not just a notice of publication (RPA).
2022-10-07 English
BOTHE_PR_2022-10-07_Pregene_Termination notice_FR_FINAL.pdf
Regulatory Filings Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release – Regulated Information) dated October 7, 2022. It discusses a significant corporate event: Bone Therapeutics recovering worldwide rights to its ALLOB platform following a unilateral termination notice from a partner (Pregene) and ongoing discussions with another partner (Link Health). This type of announcement, detailing material corporate actions, licensing changes, and strategic updates, is typically classified as a general regulatory announcement or a specific corporate action update. Since it is not a full financial report (10-K, IR), an earnings release (ER), a proxy statement (DEF 14A), or a specific transaction report (POS, SHA), and it is explicitly labeled as 'INFORMATION REGLEMENTEE', it fits best under the general regulatory filing category, RNS, as it is a material, non-standard disclosure. It is too detailed and substantive to be a simple Report Publication Announcement (RPA).
2022-10-07 French
BOTHE_PR_2022-10-06_EGM2_EN_vfinal.pdf
AGM Information Classification · 98% confidence The document is explicitly titled 'PRESS RELEASE – REGULATED INFORMATION' and announces that Bone Therapeutics will host an 'Extraordinary General Meeting on 24 October 2022'. It further states that 'The notice for the extraordinary general meeting, including the agenda of the day as well as the motions to vote, is published today...' and that 'The documents and preliminary information concerning the extraordinary general meeting have been made available...'. This content is focused on informing shareholders about an upcoming general meeting and the availability of related documents, which aligns perfectly with the purpose of an AGM-related announcement or a proxy/information statement. Since it is an announcement about an Extraordinary General Meeting (EGM), and the materials are being made available, the most specific code is AGM-R (AGM Information), as EGMs are functionally similar to AGMs regarding shareholder materials, or potentially PSI (Proxy Solicitation & Information Statement). Given the direct mention of the EGM and the availability of notice/agenda/motions, AGM-R is the primary fit for the event itself, although it also contains elements of RPA/PSI. However, the core subject is the EGM itself. I will classify it as AGM-R.
2022-10-06 English
BOTHE_PR_2022-10-06_EGM2_FR_vfinal.pdf
AGM Information Classification · 95% confidence The document is titled "COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE" (Press Release - Regulated Information) dated October 6, 2022. The main subject is the announcement that Bone Therapeutics will hold an Extraordinary General Meeting (Assemblée Générale Extraordinaire) on October 24, 2022. It explicitly states that the preparatory documents for the meeting are being made available to shareholders. This content—announcing a shareholder meeting and the availability of related materials—aligns perfectly with the purpose of a Proxy Solicitation & Information Statement (PSI), which covers materials sent to shareholders to provide information and request votes for meetings. While it is a press release, its core function here is to announce the AGM and the associated documentation, making PSI the most specific fit, although AGM-R (AGM Information) is also highly relevant. Given the focus on making preparatory documents available for the upcoming meeting, PSI is slightly more precise than just AGM-R, which often implies the presentation itself. However, since the document is primarily an announcement about the meeting and the availability of documents, and it is a formal regulatory communication, it strongly relates to the materials used for soliciting votes or informing shareholders about the meeting. Let's re-evaluate against AGM-R and PSI. AGM-R is for 'Presentations and materials shared during the AGM'. PSI is for 'Materials sent to shareholders to provide information and request votes for meetings'. Since this is the announcement *before* the meeting detailing where to find the documents for voting, PSI is a strong candidate. However, the document explicitly mentions the 'assemblée générale' and the availability of documents, which is the core function of materials related to the AGM. Given the context of a formal announcement regarding the logistics and documentation for a shareholder meeting, AGM-R (AGM Information) is the most direct classification for an announcement pertaining to the AGM itself, even if it precedes the event.
2022-10-06 French

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.